Cambridge Cognition has announced the launch of an improved electronic clinical outcomes assessment ("eCOA") platform and a new $0.225m contract with a top 10 pharmaceutical company. We view this as further validation of the Group's eCOA platform which has benefited from investment in the year. The Group is well placed in major growth markets and we have identified four key growth drivers as i) Driving further sales in its core cognitive assessment clinical trials division. The Group can save
25 Nov 2019
eCOA expansion. Contract win
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
eCOA expansion. Contract win
Cambridge Cognition Holdings Plc (COG:LON) | 54.5 -0.3 (-0.9%) | Mkt Cap: 19.1m
- Published:
25 Nov 2019 -
Author:
Thomas Like -
Pages:
5
Cambridge Cognition has announced the launch of an improved electronic clinical outcomes assessment ("eCOA") platform and a new $0.225m contract with a top 10 pharmaceutical company. We view this as further validation of the Group's eCOA platform which has benefited from investment in the year. The Group is well placed in major growth markets and we have identified four key growth drivers as i) Driving further sales in its core cognitive assessment clinical trials division. The Group can save